As an innovation leader in China's medical technology sector, Likang Xiangyun has been committed to providing outstanding solutions for global healthcare since its establishment in 1995. Integrating R&D, production, and trade, we leverage our full industrial chain advantages to become a comprehensive multinational enterprise offering a wide range of products including in vitro diagnostics, cardiovascular disease, neurovascular disease, and peripheral artery disease interventional products and medical equipment services. Our company boasts a top-notch R&D team and modern production bases in China. Core products such as heart stents and drug-coated balloons have obtained CE and MDR certifications, representing the highest level of technology in China's cardiovascular interventional treatment field. Relying on the strategic location of the Xinjiang Khorgos Special Economic Zone, we have established an international marketing network covering the Middle East, South Asia, Central Asia, Russia, and Europe, and achieve efficient cross-border distribution through the "Double West Road" logistics hub. Meanwhile, we maintain in-depth cooperation with top research institutions such as Shanghai Jiao Tong University, continuously promoting technological innovation and have achieved over 30 patent results. In terms of quality control, we strictly adhere to the ISO13485 international standard and have established a cold chain logistics system that meets GSP requirements. In the future, Likang Xiangyun will continue to deepen its market layout along the "Belt and Road" initiative, bringing more high-quality Chinese-made medical products to the world and providing safer and more effective solutions for patients globally.
Audited Supplier 
){kind=link}